KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Opko Health (OPK) Asset Writedowns and Impairment (2018 - 2019)

Opko Health's Asset Writedowns and Impairment history spans 6 years, with the latest figure at $91.7 million for Q4 2019.

For Q4 2019, Asset Writedowns and Impairment rose 321.27% year-over-year to $91.7 million; the TTM value through Sep 2020 reached $91.7 million, up 308.97%, while the annual FY2025 figure was $1.0 million, N/A changed from the prior year.
Asset Writedowns and Impairment reached $91.7 million in Q4 2019 per OPK's latest filing, up from $655000.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $91.7 million in Q4 2019 to a low of -$8.3 million in Q4 2015.
Average Asset Writedowns and Impairment over 3 years is $16.3 million, with a median of $655000.0 recorded in 2019.
The largest YoY upside for Asset Writedowns and Impairment was 15904.17% in 2015 against a maximum downside of 853.9% in 2015.
A 3-year view of Asset Writedowns and Impairment shows it stood at -$8.3 million in 2015, then skyrocketed by 362.13% to $21.8 million in 2018, then surged by 321.27% to $91.7 million in 2019.
Per Business Quant, the three most recent readings for OPK's Asset Writedowns and Impairment are $91.7 million (Q4 2019), $655000.0 (Q1 2019), and $21.8 million (Q4 2018).